Arkadios Wealth Advisors Uni Qure N.V. Transaction History

Arkadios Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$20.24 - $36.01 $16,515 - $29,384	-816 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$26.01 - $38.22 $3,875 - $5,694	149 Added 22.34%	816 $26,000
Q2 2021 Jul 28, 2021	BUY	$29.97 - $37.17 $9,530 - $11,820	318 Added 91.12%	667 $20,000
Q1 2021 Apr 26, 2021	BUY	$29.24 - $42.03 $8,538 - $12,272	292 Added 512.28%	349 $11,000
Q4 2020 Feb 09, 2021	SELL	$35.35 - $50.67 $742 - $1,064	-21 Reduced 26.92%	57 $2,000
Q3 2020 Nov 10, 2020	BUY	$35.98 - $47.66 $2,806 - $3,717	78 New	78 $2.79 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.